CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 11.50
-1.00 (-8.00%)
May 6, 2026, 4:28 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.47 million as of May 6, 2026. Its market cap has increased by 108.31% in one year.
Market Cap
6.47M
Enterprise Value
6.12M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.50
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.47M, a decrease of -77.09%. That is a compound annual growth rate of -7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 6.47M | 25.00% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 17.50M |
| IXICO | 14.99M |
| Genflow Biosciences | 14.46M |
| Cizzle Biotechnology Holdings | 10.50M |
| Oxford BioDynamics | 8.80M |
| OptiBiotix Health | 5.27M |
| Thalia Therapeutics | 4.79M |
| Theracryf | 4.73M |